Wednesday, May 27, 2015

Decisions in the cases of Kateryna Kozlova and Hamad Abbas Janahi

PRESS RELEASE
27 May 2015

Decision in the case of Kateryna Kozlova

The International Tennis Federation announced today that Kateryna Kozlova has been found to have committed an Anti-Doping Rule Violation under Article 2.1 of the Tennis Anti-Doping Programme (presence of a Prohibited Substance in a Player’s Sample).

Ms Kozlova, a 21 year-old player from Ukraine, provided a urine sample on 16 February 2015 in association with her participation in the 2015 Dubai Duty Free Tennis Championships event (the “Dubai event”) held in Dubai, UAE. That sample was sent to the WADA-accredited laboratory in Montreal, Canada for analysis, and was found to contain 1,3 dimethylbutylamine, which is a Prohibited Substance under section S6(b) (Stimulants) of the 2015 WADA List of Prohibited Substances and Prohibited Methods, and is therefore also prohibited under the Tennis Anti-Doping Programme (the “Programme”). Ms Kozlova was therefore charged with an Anti-Doping Rule Violation under Article 2.1 of the Programme.

Ms Kozlova asserted that the 1,3 dimethylbutylamine, for which she did not hold a valid TUE, had entered her system through her ingestion of a supplement provided to her by a doctor. The ITF accepted that Ms Kozlova had therefore established the means by which the 1,3 dimethylbutylamine entered her system, and that she met the preconditions of Article 10.5 of the 2015 Programme (reduction of the period of ineligibility based on no significant fault or negligence).

Ms Kozlova’s commission of an Anti-Doping Rule Violation under Article 2.1 of the Programme was confirmed, and it was determined that she is suspended from participation for a period of six months, back-dated to commence from 16 February 2015, and so ending at midnight on 15 August 2015. It was also determined that her results at the Dubai event – and all subsequent events in which she competed prior to the date of this decision – should be disqualified, with resulting forfeiture of the ranking points and prize money that she won at those events.


The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping.

 


PRESS RELEASE
27 May 2015

Decision in the case of Hamad Abbas Janahi

The International Tennis Federation announced today that Hamad Abbas Janahi has been found to have committed an Anti-Doping Rule Violation under Article 2.1 of the Tennis Anti-Doping Programme (presence of a Prohibited Substance in a Player’s Sample).

Mr Janahi, a 24 year-old player from UAE, provided a urine sample on 21 February 2015 in association with his participation in the 2015 Dubai Duty Free Tennis Championships event (the “Dubai event”) held in Dubai, UAE. That sample was sent to the WADA-accredited laboratory in Montreal, Canada for analysis, and was found to contain a metabolite of methylphenidate and 1,3-dimethylbutylamine, which are Prohibited Substances under section S6(b) (Stimulants) of the 2015 WADA List of Prohibited Substances and Prohibited Methods, and are therefore also prohibited under the Tennis Anti-Doping Programme (the “Programme”). Mr Janahi was therefore charged with an Anti-Doping Rule Violation under Article 2.1 of the Programme.

Mr Janahi’s commission of an Anti-Doping Rule Violation under Article 2.1 of the Programme was confirmed, and it was determined that he is suspended from participation for a period of two years, commencing on 27 May 2015, and so ending at midnight on 26 May 2017. It was also determined that his results at the Dubai event should be disqualified, with resulting forfeiture of the ranking points and prize money that he won at those events.


The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping.

Friday, May 22, 2015

USADA Q1 2015: Anti-doping Tests for Tennis

USADA Q1 statistics are up:

11 Athletes Selected
14 Total Tests

Athlete Name
Test Count

Michael C Bryan
2

Robert C Bryan
2

Lauren Davis
1

Jamie Hampton
1

Steve Johnson
1

Madison Keys
1

Bethanie Mattek-Sands
1

Christina M McHale
1

Jack Sock
1

Sloane Stephens
1

Venus E Williams
2

Sunday, April 19, 2015

Ricci Bitti: Words of Wisdom

The President of the ITF has dropped some absolute pearls of wisdom regarding anti-doping in tennis:
"Quantity doesn't mean quality. The program in anti-doping has to be very focused and I'm proud to say the tennis program is one of the best,'' he [Ricci Bitti] said, adding that ''there could be a little bit more'' testing.
The ITF has the right to retest samples for a period of eight years. This has been used in other Olympic sports in the past to catch drug cheats from past years using modern technology, but Ricci Bitti said the ITF very rarely used its right to reopen samples.
"We retain all our testing and we can retest,'' he said. ''I believe in sports like the Olympics, this has some value because it's one competition every four years, but we test the players continuously, so it's not so important."
I can only assume that this means that the ITF doesn't consider it necessary to retest samples related to players that have been linked to Dr. Fuentes, or Dr. del Moral, or the Biogenesis clinic.

Do we need any further evidence that the tennis anti-doping program lacks competent leadership?

Friday, April 17, 2015

Nick Kyrgios: Tweets & Deletes

Nick Kyrgios had some choice words....that he quickly deleted. Have a look here.

I wonder who he thinks should get tested instead?

Thursday, April 9, 2015

Decision in the case of Francois Trawalter

Who?

Sample collected August 29, 2014.

Ban announced April 9, 2015.

Ban expires April 28, 2015.

Wednesday, April 8, 2015

"There's a code"

Jon Wertheim writes:
"The doping issue is peculiar. You hear speculation—immeasurably more than was issued just a few years ago—and while it often comes from members of the camp rather than the locker room, you proceed on the assumption that the coach/agent/trainer/botanist of Player X wouldn’t be expressing these views if Player X weren’t similarly skeptical.

Yet when players are clipped for violations, their colleagues close ranks and decry the system, the onerous testing and the feckless administrators. I understand that there’s a code. And the sense of brotherhood (the majority are male) and collegiality is admirable. But it’s surprising to me how often the indicted player is not disgraced, but rather has the public backing of his colleagues..."

Wednesday, April 1, 2015

Big Fish

Monday, March 23, 2015

Jon & Me (Updated)

The End....?

Saturday, March 21, 2015

"A Very Sensitive Subject"


Thursday, March 19, 2015

Odesnik's Statement

Wednesday, March 18, 2015

Wayne Odesnik: Suspended from participation for a period of 15 years

18 Mar 2015

Decision in the case of Wayne Odesnik


PRESS RELEASE
18 March 2015 – London, ENGLAND - The Tennis Anti-Doping Programme (the “Programme”) and the United States Anti-Doping Agency (“USADA”) jointly announced today that Wayne Odesnik has committed a second Anti-Doping Rule Violation. 
Mr Odesnik, a 29-year-old player from the USA, provided an out-of-competition urine sample to USADA on 14 December 2014, and further samples to the ITF (on behalf of the Programme) on 17 December 2014 and 12 January 2015. Those samples were sent to WADA-accredited laboratories in Salt Lake City, USA and Montreal, Canada for analysis, and were found to contain one or more of: metabolites of methenolone; metabolites of androst-(2,3)-en-17-one; and GHRP-6. All are Prohibited Substances under the 2014 and 2015 WADA List of Prohibited Substances: methenolone under section S1 (Anabolic agents); androst-(2,3)-en-17-one under section S4 (Hormone and metabolic  modulators); and GHRP-6 under Section 2  (Peptide hormones, growth factors, related substances and mimetics). They are therefore also prohibited under the 2014 and 2015 versions of the Programme. Accordingly, Mr Odesnik was charged with an Anti-Doping Rule Violation under Article 2.1 of the Programme. 
Mr Odesnik’s commission of an Anti-Doping Rule Violation under Article 2.1 of the Programme was confirmed, which was his second such violation, having been sanctioned in 2010 for the possession of human growth hormone. It was, therefore, determined that he is suspended from participation for a period of 15 years, back-dated to commence from 30 January 2015, and so ending at midnight on 29 January 2030. It was also determined that Mr Odesnik’s results at the Happy Valley Challenger event, Australian Open and Maui Challenger event should be disqualified, with forfeiture of the ranking points and prize money that he won at those events. 
This case featured extensive cooperation between the ITF (on behalf of the Programme) and USADA, including information sharing, use of the expertise of each organisation and a consolidated approach to the results management process. These contributions are hereby recognised and held up as an example of the benefits of cooperation between Anti-Doping Organisations. 
The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping
USADA is a signatory to the World Anti-Doping Code and fully complies with the World Anti-Doping Code’s International Standards. USADA runs the anti-doping program including education, sample collection, results management, and drug reference resources for athletes in US Olympic, Paralympic, Pan American, and Parapan American Sport, including all Olympic sport national governing bodies, their athletes, and events throughout the year. Additionally, USADA’s commitment to clean competition and the integrity of competition also includes programs aimed at scientific research and education & outreach initiatives focused on awareness and prevention.

Read more at http://www.itftennis.com/news/202429.aspx#7jbUPpyAFBlpUXPU.99

Sunday, March 8, 2015

Surprised?

How many sports could this phrase be applied to?
“For a long time, the main focus of U.C.I. leadership was on the growth of the sport worldwide, and its priority was to protect the sport’s reputation; doping was perceived as a threat to this...the emphasis of U.C.I.’s antidoping policy was, therefore, to give the impression that U.C.I. was tough on doping rather than actually being good at antidoping.”

Tuesday, March 3, 2015

Murray, Walsh, and Armstrong

The recent edition of The Sunday Times (subscription required) features a piece by renowned anti-doping cycling journalist David Walsh interviewing Andy Murray. During the interview, Murray asked Walsh a series of questions about Lance Armstrong:
"We're about to leave when he brings up Lance Armstrong. What can you tell me, he asks. I want to play the small-time mafia guy in the interrogation room: I know nothing. But Murray is not taking no as an answer. He has seen the documentaries, he has read the books and he needs more. The gym where he does his peak oxygen uptake testing used to have an Armstrong poster on the wall and before the Texan was banned, he said to the lady in charge he thought she should take it down.

"The poster has gone now, as have the two Livestrong bikes at another gym he uses in the US. Murray wants to know about the $10m (PS6.5m) Armstrong has been ordered to pay SCA Promotions and how many cyclists died from EPO abuse and what happened to the blood bags in the Eufemiano Fuentes case and why they weren't analysed."
One hopes that this is the just the beginning of Walsh getting involved with tennis.